[{"address1": "4868 Rue Levy", "address2": "Suite 220", "city": "Montreal", "state": "QC", "zip": "H4R 2P1", "country": "Canada", "phone": "514 332 4888", "website": "https://www.engene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Gu\u00e9rin (BCG). enGene Holdings Inc. is based in Montreal, Canada.", "fullTimeEmployees": 56, "companyOfficers": [{"maxAge": 1, "name": "Dr. Anthony T. Cheung Ph.D.", "age": 52, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 341754, "exercisedValue": 0, "unexercisedValue": 13448566}, {"maxAge": 1, "name": "Mr. John C. Brown D.Sc., FRSC, Ph.D.", "title": "Co-Founder and Member of Scientific Advisory Board", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Ryan Daws", "age": 50, "title": "CFO & Head of Business Development", "yearBorn": 1974, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Boyd", "title": "Senior VP of Regulatory Affairs", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jill  Buck", "age": 50, "title": "Senior VP of Clinical Development Operations", "yearBorn": 1974, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.4, "open": 3.43, "dayLow": 3.29, "dayHigh": 3.69, "regularMarketPreviousClose": 3.4, "regularMarketOpen": 3.43, "regularMarketDayLow": 3.29, "regularMarketDayHigh": 3.69, "payoutRatio": 0.0, "beta": -0.354, "forwardPE": -2.04142, "volume": 89404, "regularMarketVolume": 89404, "averageVolume": 60322, "averageVolume10days": 131800, "averageDailyVolume10Day": 131800, "bid": 3.33, "ask": 3.5, "bidSize": 1, "askSize": 1, "marketCap": 176194608, "fiftyTwoWeekLow": 2.65, "fiftyTwoWeekHigh": 13.28, "fiftyDayAverage": 4.2502, "twoHundredDayAverage": 6.42265, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12807418, "profitMargins": 0.0, "floatShares": 24461582, "sharesOutstanding": 51070900, "sharesShort": 69717, "sharesShortPriorMonth": 37191, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.13581, "heldPercentInstitutions": 0.90910006, "shortRatio": 1.39, "shortPercentOfFloat": 0.0018000001, "impliedSharesOutstanding": 51070900, "bookValue": 4.903, "priceToBook": 0.70365083, "lastFiscalYearEnd": 1730332800, "nextFiscalYearEnd": 1761868800, "mostRecentQuarter": 1738281600, "netIncomeToCommon": -69047000, "trailingEps": -1.48, "forwardEps": -1.69, "enterpriseToEbitda": 0.164, "52WeekChange": -0.7277032, "SandP52WeekChange": 0.12250078, "quoteType": "EQUITY", "currentPrice": 3.45, "targetHighPrice": 34.0, "targetLowPrice": 7.0, "targetMeanPrice": 23.36364, "targetMedianPrice": 25.0, "recommendationKey": "none", "numberOfAnalystOpinions": 11, "totalCash": 213812992, "totalCashPerShare": 4.194, "ebitda": -78024000, "totalDebt": 25133000, "quickRatio": 16.537, "currentRatio": 17.161, "debtToEquity": 10.055, "returnOnAssets": -0.25747, "returnOnEquity": -0.44213, "freeCashflow": -44704500, "operatingCashflow": -66607000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ENGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.4705868, "regularMarketPrice": 3.45, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1643725800000, "postMarketChangePercent": -4.92754, "postMarketPrice": 3.28, "postMarketChange": -0.17, "longName": "enGene Holdings Inc.", "regularMarketChange": 0.049999952, "regularMarketDayRange": "3.29 - 3.69", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 60322, "fiftyTwoWeekLowChange": 0.79999995, "fiftyTwoWeekLowChangePercent": 0.30188677, "fiftyTwoWeekRange": "2.65 - 13.28", "fiftyTwoWeekHighChange": -9.83, "fiftyTwoWeekHighChangePercent": -0.74021083, "fiftyTwoWeekChangePercent": -72.770325, "earningsTimestamp": 1741637100, "earningsTimestampStart": 1749610800, "earningsTimestampEnd": 1750906800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.48, "epsForward": -1.69, "epsCurrentYear": -1.94465, "priceEpsCurrentYear": -1.7740982, "fiftyDayAverageChange": -0.80019975, "fiftyDayAverageChangePercent": -0.18827344, "twoHundredDayAverageChange": -2.9726498, "twoHundredDayAverageChangePercent": -0.46283853, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-11-01", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1747435382, "regularMarketTime": 1747425600, "exchange": "NCM", "messageBoardId": "finmb_9516520", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "enGene Holdings Inc.", "displayName": "enGene", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]